Why the study?
Does implantable cardioverter defibrillator therapy improve survival in patients with end-stage kidney disease on dialysis?
Population
Patients with end-stage kidney disease on dialysis
Design
Review
Authors
Loading...
Primary prevention ICDs warrant caution in dialysis patients; leaves open secondary benefits and need for dedicated RCTs.
Does implantable cardioverter defibrillator therapy improve survival in patients with end-stage kidney disease on dialysis?
Current ICD guidelines may not directly apply to ESKD patients due to their exclusion from major trials, highlighting the need for dedicated studies in this high-risk population.
O’Shaughnessy et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: